Lifeward Ltd. (NASDAQ:LFWD) Short Interest Update

Lifeward Ltd. (NASDAQ:LFWD) was the target of a large decline in short interest in February. As of February 27th, there was short interest totaling 228,488 shares, a decline of 90.3% from the February 12th total of 2,351,929 shares. Based on an average daily volume of 41,420 shares, the days-to-cover ratio is presently 5.5 days. Approximately 15.2% of the company’s stock are sold short. Approximately 15.2% of the company’s stock are sold short. Based on an average daily volume of 41,420 shares, the days-to-cover ratio is presently 5.5 days.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on LFWD. HC Wainwright dropped their price objective on shares of Lifeward from $156.00 to $54.00 and set a “buy” rating on the stock in a research note on Tuesday, November 18th. Weiss Ratings restated a “sell (e+)” rating on shares of Lifeward in a report on Thursday, January 22nd. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $51.00.

Lifeward Price Performance

Shares of LFWD stock traded up $0.29 during mid-day trading on Tuesday, hitting $6.35. 6,502 shares of the stock traded hands, compared to its average volume of 27,447. The stock has a market cap of $9.65 million, a P/E ratio of -0.18 and a beta of 0.12. The stock’s fifty day moving average is $6.98 and its two-hundred day moving average is $7.43. Lifeward has a 52-week low of $4.14 and a 52-week high of $35.40.

Institutional Investors Weigh In On Lifeward

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. HRT Financial LP boosted its stake in Lifeward by 149.7% in the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after acquiring an additional 29,423 shares in the last quarter. Jane Street Group LLC grew its holdings in Lifeward by 77.3% in the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after purchasing an additional 29,927 shares during the last quarter. Virtu Financial LLC lifted its holdings in shares of Lifeward by 158.0% during the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock valued at $35,000 after purchasing an additional 37,037 shares during the last quarter. Finally, Citadel Advisors LLC lifted its holdings in shares of Lifeward by 1,271.8% during the 3rd quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after purchasing an additional 198,406 shares during the last quarter. Hedge funds and other institutional investors own 26.76% of the company’s stock.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.